Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Medicinal Chemistry
|
February 22, 2008
Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology
Alex M Aronov, Brian McClain, Cameron Stuver Moody, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Synthesis of a 6-Aza-Isoindolinone-Based Inhibitor of Phosphoinositide 3-Kinase γ via Ruthenium-Catalyzed [2 + 2 + 2] Cyclotrimerization
Philip N Collier, Advaita Panchagnula, Hardwin O'Dowd, et al.
Journal of Chemical Information and Modeling
|
August 26, 2016
Prediction of Protein Pairs Sharing Common Active Ligands Using Protein Sequence, Structure, and Ligand Similarity
Yu-Chen Chen, Robert Tolbert, Alex M Aronov, et al.
Journal of Chemical Information and Modeling
|
March 6, 2020
Smallest Maximum Intramolecular Distance: A Novel Method to Mitigate Pregnane Xenobiotic Receptor Activation
Michael J Bower, Alex M Aronov, Thomas Cleveland, et al.
Journal of Medicinal Chemistry
|
April 24, 2014
Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ
Philip N Collier, Gabriel Martinez-Botella, Mark Cornebise, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors
Upul K Bandarage, Alex M Aronov, Jingrong Cao, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2021
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors
Qing Tang, Alex M Aronov, David D Deininger, et al.
Journal of Medicinal Chemistry
|
February 16, 2007
Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors
Alex M Aronov, Christopher Baker, Guy W Bemis, et al.
Journal of Medicinal Chemistry
|
July 8, 2016
Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors
Dominique Bonafoux, Suganthini Nanthakumar, Upul K Bandarage, et al.
Molecular Cancer Therapeutics
|
September 24, 2017
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
Ursula A Germann, Brinley F Furey, William Markland, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Medicinal Chemistry
|
February 22, 2008
Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology
Alex M Aronov, Brian McClain, Cameron Stuver Moody, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Synthesis of a 6-Aza-Isoindolinone-Based Inhibitor of Phosphoinositide 3-Kinase γ via Ruthenium-Catalyzed [2 + 2 + 2] Cyclotrimerization
Philip N Collier, Advaita Panchagnula, Hardwin O'Dowd, et al.
Journal of Chemical Information and Modeling
|
August 26, 2016
Prediction of Protein Pairs Sharing Common Active Ligands Using Protein Sequence, Structure, and Ligand Similarity
Yu-Chen Chen, Robert Tolbert, Alex M Aronov, et al.
Journal of Chemical Information and Modeling
|
March 6, 2020
Smallest Maximum Intramolecular Distance: A Novel Method to Mitigate Pregnane Xenobiotic Receptor Activation
Michael J Bower, Alex M Aronov, Thomas Cleveland, et al.
Journal of Medicinal Chemistry
|
April 24, 2014
Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ
Philip N Collier, Gabriel Martinez-Botella, Mark Cornebise, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors
Upul K Bandarage, Alex M Aronov, Jingrong Cao, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2021
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors
Qing Tang, Alex M Aronov, David D Deininger, et al.
Journal of Medicinal Chemistry
|
February 16, 2007
Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors
Alex M Aronov, Christopher Baker, Guy W Bemis, et al.
Journal of Medicinal Chemistry
|
July 8, 2016
Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors
Dominique Bonafoux, Suganthini Nanthakumar, Upul K Bandarage, et al.
Molecular Cancer Therapeutics
|
September 24, 2017
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
Ursula A Germann, Brinley F Furey, William Markland, et al.
Page
of 3